Opko Health Inc. (OPK) Reaches $5.51 Yearly Low; Shorts at Hmn Financial (HMNF) Raised By 50%

November 9, 2017 - By Henry Gaston

The stock of Opko Health Inc. (NASDAQ:OPK) hit a new 52-week low and has $5.34 target or 3.00% below today’s $5.51 share price. The 7 months bearish chart indicates high risk for the $3.08 billion company. The 1-year low was reported on Nov, 9 by Barchart.com. If the $5.34 price target is reached, the company will be worth $92.40M less. About 6.70 million shares traded or 84.07% up from the average. Opko Health Inc. (NASDAQ:OPK) has declined 32.62% since November 9, 2016 and is downtrending. It has underperformed by 49.32% the S&P500.

Hmn Financial Incorporated (NASDAQ:HMNF) had an increase of 50% in short interest. HMNF’s SI was 900 shares in November as released by FINRA. Its up 50% from 600 shares previously. With 1,900 avg volume, 1 days are for Hmn Financial Incorporated (NASDAQ:HMNF)’s short sellers to cover HMNF’s short positions. The SI to Hmn Financial Incorporated’s float is 0.03%. About 434 shares traded. HMN Financial, Inc. (NASDAQ:HMNF) has risen 39.52% since November 9, 2016 and is uptrending. It has outperformed by 22.82% the S&P500.

Since May 10, 2017, it had 19 insider purchases, and 0 insider sales for $5.93 million activity. $165,786 worth of Opko Health Inc. (NASDAQ:OPK) shares were bought by FROST PHILLIP MD ET AL. Rubin Steven D also bought $13,814 worth of Opko Health Inc. (NASDAQ:OPK) shares. $63,135 worth of Opko Health Inc. (NASDAQ:OPK) was bought by LERNER RICHARD A. The insider PAGANELLI JOHN A bought $30,840. HSIAO JANE PH D bought $138,500 worth of stock.

OPKO Health, Inc. is a healthcare company. The company has market cap of $3.08 billion. The Company’s divisions include Pharmaceutical, Diagnostics and Corporate. It currently has negative earnings. Pharmaceutical consists of the pharmaceutical activities in Chile, Mexico, Ireland, Israel and Spain and its pharmaceutical research and development operations.

Investors sentiment decreased to 1.03 in 2017 Q2. Its down 0.04, from 1.07 in 2017Q1. It turned negative, as 33 investors sold Opko Health Inc. shares while 55 reduced holdings. 26 funds opened positions while 65 raised stakes. 119.98 million shares or 1.70% less from 122.05 million shares in 2017Q1 were reported. Paloma Mgmt Com has invested 0.01% in Opko Health Inc. (NASDAQ:OPK). Van Eck Associate owns 100,468 shares. Wells Fargo & Mn owns 0% invested in Opko Health Inc. (NASDAQ:OPK) for 420,908 shares. The Illinois-based Balyasny Asset Mgmt Ltd Company has invested 0% in Opko Health Inc. (NASDAQ:OPK). Rk Asset Management Ltd reported 906,731 shares. Profund Limited Liability Company holds 0.04% of its portfolio in Opko Health Inc. (NASDAQ:OPK) for 138,581 shares. Moreover, Public Employees Retirement Association Of Colorado has 0% invested in Opko Health Inc. (NASDAQ:OPK). Teacher Retirement Of Texas, a Texas-based fund reported 26,863 shares. Dekabank Deutsche Girozentrale invested in 0.01% or 251,274 shares. Next Financial Group invested in 0% or 200 shares. Voya Invest Lc accumulated 96,709 shares. Moreover, Mivtachim The Workers Social Insurance Fund (Under Special Management) has 1.4% invested in Opko Health Inc. (NASDAQ:OPK) for 3.20M shares. California State Teachers Retirement Systems has 0.01% invested in Opko Health Inc. (NASDAQ:OPK). Price T Rowe Assoc Md holds 67,793 shares. Blackrock owns 22.90M shares for 0.01% of their portfolio.

HMN Financial, Inc. is a stock savings bank holding firm that owns Home Federal Savings Bank (the Bank). The company has market cap of $83.65 million. The Bank operates retail banking and loan production facilities in Minnesota, Iowa and Wisconsin. It has a 15.8 P/E ratio. The Bank has two subsidiaries, Osterud Insurance Agency, Inc., which offers financial planning services and products, and HFSB Property Holdings, LLC, which acts as an intermediary for the Bank in holding and operating certain foreclosed properties.